茜草属药用植物的研究——Ⅲ.11种茜草属药材的组织形成学研究

本文除对主流商品茜草的生药性状和组织构造作了较全面的描述,还利用图、表及照片列出狭叶茜草P.truppeliana Loes、Loeb、小红参(滇茜草)R.yunnomensis Dtels、中华茜草R.chinensis Regel et maack、大叶茜草R.schumanniana Pritz、按针叶茜草R.lanceolata Hayata、大茜草R.magna Hisao、钩毛茜草R.oncotrucha Hand-Mazz、红花茜草R.podantha Diels、金剑草R.alata Wall、新疆茜草(洋茜草)R.tinctorum L等10种与茜草Rubia cordifolia L的主要区别点,并作药材检索表,以利鉴别。     

栽培稻杂种不育性的遗传研究——Ⅲ.不同类型品种F_1花粉不育性的等位基因分化

以台中65等基因F_1不育系为遗传测验种,测定了栽培稻(O.sativa)45个品种在3个F_1不育基因座的基因型和等位基因的分化度。在S-E3基因座上,除Dular带有S_i/S_i基因型外,其余被测品种均带有S_i/S_i基因型。在S-E2和S-E5基因座上,籼型品种带有高频率的S_i基因,而粳型品种带有高频率的S_i基因。S_i和S_i均具有不同的分化度。籼型品种携带的S_i基因和粳型品种携带的S_i基因具有较高的分化度。中间型品种和广亲和品种的等位基因分化在S-E2基因座上与粳型品种相似,而在S-E5基因座上与籼型品种相似。此外,分析了各类型品种相互杂交F_1杂种在S-E2和S-E5基因座的杂合率、杂合度和杂合性。与籼/粳杂种相比,中间型品种(包括广亲和品种)与籼型和粳型品种杂交,F_1杂种均具有较低的平均杂合性,从而表现出较高的亲和性。因此,无论是杂种不育性还是杂种亲和性均由花粉不育基因控制。花粉不育基因也称为特异亲和基因。     

ent-Pimarane Diterpenes from the Aerial Parts of Siegesbeckia pubescens

Five new ent-pimarane diterpenes ( 1 – 5 ) and five known analogs ( 6 – 10 ) were isolated from the aerial parts of Siegesbeckia pubescens. Their structures, including absolute configurations, were determined by comprehensive spectroscopic methods especially 1D and 2D NMR and quantum chemical electronic circular dichroism calculations. All the isolated compounds were evaluated for their cytotoxicity against human BT549, A549 and H157 cancer cell lines. Among them, compounds 1 and 2 showed mild cytotoxicity against lung cancer cell lines H157 with IC₅₀ values of 16.35±2.59 and 18.86±4.83 μM, respectively.     

Applying single-cell highly multiplexed secretome proteomics to characterize immunotherapeutic products and predict clinical responses

Genetically and phenotypically identical immune cell populations can be highly heterogenous in terms of their immune functions and protein secretion profiles. The microfluidic chip-based single-cell highly multiplexed secretome proteomics enables characterization of cellular heterogeneity of immune responses at different cellular and molecular layers. Increasing evidence has demonstrated that polyfunctional T cells that simultaneously produce 2+ proteins per cell at the single-cell level are key effector cells that contribute to the development of potent and durable cellular immunity against pathogens and cancers. The functional proteomic technology offers a wide spectrum of cellular function assessment and can uniquely define highly polyfunctional cell subsets with cytokine signatures from live individual cells. This high-dimensional single-cell analysis provides deep dissection into functional heterogeneity and helps identify predictive biomarkers and potential correlates that are crucial for immunotherapeutic product design optimization and personalized immunotherapy development to achieve better clinical outcomes.